For instance, downregulation of LINC00460 inhibited the growth and promoted the apoptosis of pancreatic cancer cells, showing potential as a novel biomarker and promising therapeutic strategy for pancreatic cancer [25]. This evidence concerns the gene LINC00460 and familial pancreatic carcinoma.